ORPEA |
Market Closed -
Other stock markets
|
After market 03:10:50 pm | |||
| 12.49 EUR | -3.18% |
|
12.48 | -0.08% |
| May. 15 | ORPEA : Challenging recovery in France, adequate elsewhere |  |
| May. 15 | Oddo BHF Upgrades Emeis to Neutral from Underperform, Lifts PT | MT |
| Sales 2024 * | 5.63B 6.13B | Sales 2025 * | 5.99B 6.52B | Capitalization | 2.05B 2.23B |
|---|---|---|---|---|---|
| Net income 2024 * | -292M -318M | Net income 2025 * | -175M -190M | EV / Sales 2024 * | 1.7 x |
| Net Debt 2024 * | 7.51B 8.17B | Net Debt 2025 * | 6.21B 6.75B | EV / Sales 2025 * | 1.38 x |
| P/E ratio 2024 * |
-0.01
x | P/E ratio 2025 * |
-0.01
x | Employees | 62,806 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.16% |
More Fundamentals
* Assessed data
More news
Latest transcript on ORPEA
More press releases
More news
| 1 day | -0.45% | ||
| 1 week | -12.04% | ||
| Current month | +0.36% | ||
| 1 month | -5.54% | ||
| 3 months | +14.70% | ||
| 6 months | -94.51% | ||
| Current year | -23.99% |
1 week
12.51
15.30
1 month
12.5115.30
Current year
9.9718.10
1 year
9.972 800.00
3 years
9.97111 100.00
5 years
9.97129 000.00
10 years
9.97129 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Laurent Lemaire
DFI | Director of Finance/CFO | - | 21-12-07 |
| Chief Tech/Sci/R&D Officer | - | 22-10-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 22-07-27 | |
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Mireille Faugère
BRD | Director/Board Member | 66 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 17 M€ | +7.83% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 12.49 | -3.18% | 607 306 |
| 24-05-27 | 12.9 | +1.10% | 434,734 |
| 24-05-24 | 12.76 | -10.38% | 875,880 |
| 24-05-23 | 14.24 | -1.37% | 238,412 |
| 24-05-22 | 14.44 | -1.12% | 606,742 |
Real-time Euronext Paris, May 28, 2024 at 03:13 am EDT
More quotes
ORPEA is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics. At the end of 2023, ORPEA had a network of 1,031 facilities (93,470 beds) located in France/Benelux/United Kingdom/Ireland (574 facilities; 45,431 beds), Central Europe (247; 24,316 beds), Eastern Europe (124; 12,764 beds), the Iberian Peninsula and Latin America (83; 10,394 beds), China (2; 154 beds) and the United Arab Emirates (1; 36 beds).
As of December 31st , 2023, the estimated value of the real estate portfolio was EUR 6.3 billion.
Net sales are distributed geographically as follows: France/Benelux/the United Kingdom/Ireland (58.4%), Central Europe (26%), Eastern Europe (9.9%), Iberian Peninsula and Latin America (5.5%) and other (0.2%).
Calendar
2024-06-25
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.9
EUR
Average target price
11,725
EUR
Spread / Average Target
+90,763.30%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.99% | 2.23B | |
| +10.72% | 1.58B | |
| +15.98% | 1.3B | |
| -30.62% | 1.31B | |
| +27.07% | 781M | |
| -12.73% | 432M | |
| +218.32% | 404M | |
| -11.47% | 320M | |
| +21.08% | 80.22M |
- Stock Market
- Equities
- ORP Stock
